Saturn V Capital Management LP

CIK

1964437

Location

AUSTIN, TX

Portfolio Value

Small $552,217,503

Diversification

Diversified

Filing Date

Global Rank

#2,472 / 8,623 ▲ 63 · as of Mar 2026

Top Industry

Biotechnology 89.1%

3Y Alpha vs SPY

+21.2%

Period ended 4 months ago

Filed May 15, 2026 · 3mo

14 quarters · since Dec 2022

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+179.3%

SPY

+67.9%

Annualised alpha

+22.0%

Max drawdown

−46.2%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

21 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

12.8%

−3.3 pts

Top 5

49.5%

+1.0 pts

Top 10

77.0%

+0.6 pts

HHI

734

Diversified−24

Portfolio Trend

14 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$552,217,503	21

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

10 positions

Ticker	Company	Δ Shares	Shares	Value
IVVD	Invivyd, Inc.	+3,213,698	10,949,084	$14,233,809
OVID	Ovid Therapeutics Inc.	+1,666,666	4,166,666	$9,249,998
IMMX	Immix Biopharma, Inc.	+694,416	3,693,585	$33,648,559
XFOR	X4 Pharmaceuticals, Inc	+656,116	6,456,646	$26,665,947
IRON	Disc Medicine, Inc.	+151,497	449,926	$28,768,268
ALMS	Alumis Inc.	+66,122	3,202,075	$70,541,712
PHVS	Pharvaris N.V.	+61,369	1,201,402	$33,939,606
PCVX	Vaxcyte, Inc.	+25,592	824,532	$47,913,554
MNPR	Monopar Therapeutics	+19,925	345,626	$18,936,848
IKT	Inhibikase Therapeutics, Inc.	+6,646	3,863,445	$6,490,587
No positions match the current search.

Trimmed

Positions the filer reduced

6 positions

Ticker	Company	Δ Shares	Shares	Value
DYN	Dyne Therapeutics, Inc.	−822,007	966,609	$17,524,621
COGT	Cogent Biosciences, Inc.	−590,429	626,635	$24,119,181
AMLX	Amylyx Pharmaceuticals, Inc.	−146,602	4,349,885	$60,463,401
ABVX	Abivax S.A.	−106,483	542,696	$60,429,199
JAZZ	Jazz Pharmaceuticals plc	−85,109	162,961	$30,807,777
CELC	Celcuity Inc.	−35,191	281,904	$32,176,522
No positions match the current search.

New Positions

Positions the filer opened this quarter

4 positions

Ticker	Company	Shares	Value
CADL	Candel Therapeutics, Inc.	2,896,588	$14,193,281
ZURA	Zura Bio Ltd	739,960	$4,402,762
ANRO	Alto Neuroscience, Inc.	88,999	$2,000,697
MSLE	Satellos Bioscience Inc.	350,000	$1,970,500
No positions match the current search.

Sold Out

Positions the filer fully exited

3 positions

Ticker	Company	Shares	Value
OCUL	Ocular Therapeutix, Inc	1,504,880	$18,269,243
CNTA	Centessa Pharmaceuticals plc	282,692	$7,070,126
IVA	Inventiva S.A.	283,166	$1,316,721
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

21 tracked positions · $552,217,503 total · filing declares 21 positions · $552,217,513 · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
ALMS	Alumis Inc. Healthcare	Added	3,202,075	+66,122	$70,541,712	+130.5%	12.77%
AMLX	Amylyx Pharmaceuticals, Inc. Healthcare	Reduced	4,349,885	-146,602	$60,463,401	+11.3%	10.95%
ABVX	Abivax S.A. Healthcare	Reduced	542,696	-106,483	$60,429,199	−31.0%	10.94%
PCVX	Vaxcyte, Inc. Healthcare	Added	824,532	+25,592	$47,913,554	+30.0%	8.68%
PHVS	Pharvaris N.V. Healthcare	Added	1,201,402	+61,369	$33,939,606	+7.3%	6.15%
IMMX	Immix Biopharma, Inc. Healthcare	Added	3,693,585	+694,416	$33,648,559	+114.5%	6.09%
CELC	Celcuity Inc. Healthcare	Reduced	281,904	-35,191	$32,176,522	+1.7%	5.83%
JAZZ	Jazz Pharmaceuticals plc Healthcare	Reduced	162,961	-85,109	$30,807,777	−26.9%	5.58%
IRON	Disc Medicine, Inc. Healthcare	Added	449,926	+151,497	$28,768,268	+21.4%	5.21%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Added	6,456,646	+656,116	$26,665,947	+14.9%	4.83%
COGT	Cogent Biosciences, Inc. Healthcare	Reduced	626,635	-590,429	$24,119,181	−44.2%	4.37%
MNPR	Monopar Therapeutics Healthcare	Added	345,626	+19,925	$18,936,848	−11.0%	3.43%
DYN	Dyne Therapeutics, Inc. Healthcare	Reduced	966,609	-822,007	$17,524,621	−49.9%	3.17%
IVVD	Invivyd, Inc. Healthcare	Added	10,949,084	+3,213,698	$14,233,809	−25.5%	2.58%
CADL	Candel Therapeutics, Inc. Healthcare	NEW	2,896,588	NEW	$14,193,281	NEW	2.57%
OCS	Oculis Holding AG Healthcare	Held	516,761	0	$13,740,674	+33.1%	2.49%
OVID	Ovid Therapeutics Inc. Healthcare	Added	4,166,666	+1,666,666	$9,249,998	+127.0%	1.68%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Added	3,863,445	+6,646	$6,490,587	−17.9%	1.18%
ZURA	Zura Bio Ltd Healthcare	NEW	739,960	NEW	$4,402,762	NEW	0.80%
ANRO	Alto Neuroscience, Inc. Healthcare	NEW	88,999	NEW	$2,000,697	NEW	0.36%
MSLE	Satellos Bioscience Inc. Healthcare	NEW	350,000	NEW	$1,970,500	NEW	0.36%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.